Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
74.97
+0.11 (0.15%)
Dec 5, 2025, 4:00 PM EST - Market closed
Hologic Employees
Hologic had 7,070 employees as of September 27, 2025. The number of employees increased by 7 or 0.10% compared to the previous year.
Employees
7,070
Change (1Y)
7
Growth (1Y)
0.10%
Revenue / Employee
$579,986
Profits / Employee
$80,014
Market Cap
16.71B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 27, 2025 | 7,070 | 7 | 0.10% |
| Sep 30, 2024 | 7,063 | 73 | 1.04% |
| Sep 30, 2023 | 6,990 | 46 | 0.66% |
| Sep 24, 2022 | 6,944 | 239 | 3.56% |
| Sep 25, 2021 | 6,705 | 891 | 15.33% |
| Sep 26, 2020 | 5,814 | -664 | -10.25% |
| Sep 28, 2019 | 6,478 | 226 | 3.61% |
| Sep 29, 2018 | 6,252 | 19 | 0.30% |
| Sep 30, 2017 | 6,233 | 900 | 16.88% |
| Sep 24, 2016 | 5,333 | 43 | 0.81% |
| Sep 26, 2015 | 5,290 | -61 | -1.14% |
| Sep 27, 2014 | 5,351 | -264 | -4.70% |
| Sep 28, 2013 | 5,615 | -542 | -8.80% |
| Sep 29, 2012 | 6,157 | 1,138 | 22.67% |
| Sep 24, 2011 | 5,019 | 799 | 18.93% |
| Sep 25, 2010 | 4,220 | 261 | 6.59% |
| Sep 26, 2009 | 3,959 | 26 | 0.66% |
| Oct 25, 2008 | 3,933 | 353 | 9.86% |
| Nov 12, 2007 | 3,580 | 1,963 | 121.40% |
| Nov 17, 2006 | 1,617 | 747 | 85.86% |
| Nov 19, 2005 | 870 | 109 | 14.32% |
| Nov 30, 2004 | 761 | 39 | 5.40% |
| Nov 30, 2003 | 722 | -7 | -0.96% |
| Nov 30, 2002 | 729 | -51 | -6.54% |
| Nov 30, 2001 | 780 | -66 | -7.80% |
| Nov 30, 2000 | 846 | 410 | 94.04% |
| Nov 30, 1999 | 436 | 40 | 10.10% |
| Nov 30, 1998 | 396 | 57 | 16.81% |
| Nov 30, 1997 | 339 | 45 | 15.31% |
| Nov 30, 1996 | 294 | 103 | 53.93% |
| Nov 30, 1995 | 191 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HOLX News
- 3 days ago - New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration - Business Wire
- 10 days ago - New Clinical Evidence on Hologic's AI-Powered Mammography Solutions Will Be Unveiled at RSNA - Business Wire
- 23 days ago - Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking - Business Wire
- 4 weeks ago - Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025 - Business Wire
- 6 weeks ago - Hologic Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX - Business Wire
- 6 weeks ago - Blackstone, TPG to Buy Hologic for Up to $18.3 Billion - WSJ
- 6 weeks ago - Blackstone, TPG to acquire medical device maker Hologic in up to $18.3 billion deal - Reuters
- 6 weeks ago - Hologic to be Acquired by Blackstone and TPG for up to $79 per Share - Business Wire